Financials

Company Profile

Valeritas Holdings Inc is a United States-based company. The Company provides surgical & medical instruments & apparatus.

Employees

Sector

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-4.76%	-96.52%

20-06-30	Valeritas Holdings, Inc. Went Out of Business	CI
20-06-08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI

20-06-30	Valeritas Holdings, Inc. Went Out of Business	CI
20-06-08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI
20-06-03	First Motion for Exclusivity Period Extension Approved For Valeritas Holdings, Inc.	CI
20-05-21	First Motion for Exclusivity Period Extension Filed by Valeritas Holdings, Inc.	CI
20-04-21	Combined Disclosure Statement and Liquidation Plan Approved for Solicitation Purpose on Interim Basis for Valeritas Holdings, Inc.	CI
20-04-15	First Amended Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
20-04-06	Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
20-04-02	Valeritas Holdings, Inc. Announces Management Changes	CI
20-04-01	Zealand Pharma A/S completed the acquisition of substantially all assets of Valeritas Holdings, Inc.	CI
20-03-20	Motion for Asset Sale Approved for Valeritas Holdings, Inc.	CI
20-03-13	Final DIP Financing Approved for Valeritas Holdings, Inc.	CI
20-03-13	Notice for Auction Cancellation Filed by Valeritas Holdings, Inc.	CI
20-03-06	Bidding Procedure Approved for Valeritas Holdings, Inc.	CI

20-04-02	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
20-03-23	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PU
20-03-20	VALERITAS HOLDINGS INC. : Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-03-20	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PR
20-03-18	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALERITAS HOLDINGS, INC.	-.--%	-4.76%	-	-	167K
ABBOTT LABORATORIES	+0.56%	-2.64%	-34.62%	-14.12%	154B
MEDTRONIC PLC	+0.22%	-1.58%	-7.90%	-8.57%	103B
HOYA CORPORATION	+0.79%	+1.10%	+59.84%	+48.60%	55.22B
CENCORA, INC.	-0.09%	+2.32%	-4.77%	+57.18%	54.8B
BECTON, DICKINSON AND COMPANY	-0.49%	-3.73%	-15.50%	-42.56%	40.3B
MEDLINE INC.	+1.97%	+11.07%	-	-	30.96B
DEXCOM, INC.	-1.53%	+1.87%	-9.48%	-41.59%	29.08B
WEST PHARMACEUTICAL SERVICES, INC.	+0.79%	+5.38%	+49.35%	-6.56%	23.23B
TERUMO CORPORATION	+1.70%	-1.89%	-14.26%	-1.74%	20.25B
Average	+0.39%	+0.31%	+2.83%	-1.17%	51.04B
Weighted average by Cap.	+0.38%	-0.48%	-6.53%	-0.72%